Matthias Fante

Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy

Kathrin Renner, Annette Schnell, Gudrun E. Koehl et al. · Cell Reports · 2019 · 286 citations · Full text

GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

Wolfgang Bethge, Peter Martus, Michael Schmitt et al. · Blood · 2022 · 210 citations · Full text

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

Christoph K. Stein‐Thoeringer, Neeraj Saini, Eli Zamir et al. · Nature Medicine · 2023 · 206 citations · Full text

Dysbiosis, Cancer Immunosurveillance, Mucosal Immunology +10

Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2‐deoxy‐glucose affects effector functions

Kathrin Renner, Anna‐Lena Geiselhöringer, Matthias Fante et al. · European Journal of Immunology · 2015 · 86 citations

Heat-Inactivation of Human Serum Destroys C1 Inhibitor, Pro-motes Immune Complex Formation, and Improves Human T Cell Function

Matthias Fante, Sonja-Maria Decking, Stephan Schreml et al. · International Journal of Molecular Sciences · 2021 · 23 citations · Full text

Clinical Immunology, Adaptive Immune System, T-regulatory Cell +23